Literature DB >> 803218

Serum IgD and IgE concentrations in immunodeficiency diseases.

R H Buckley, S A Fiscus.   

Abstract

Concentrations of IgD and IgE were measured in sera from 165 patients with well-defined immunodeficiency in an effort to find information possibly relevant to the roles of antibodies of these classes in host defense. Values for both immunoglobulins were generally quite low in patients who had marked deficiencies of all three major immunoglobulins, although occasional normal or high normal values for IgD were seen in hypogammaglobulinemic patients. Group mean IgD concentrations were also depressed in patients with Wiskott-Aldrich syndrome and in those with selective IgA deficiency; IgE concentrations were depressed in patients with X-linked immunodeficiency with hyper-IgM and in those with ataxia telangiectasia. IgD and IgE were both significantly elevated in patients with extreme hyperimmunoglobulinemia E and undue susceptibility to infection and in a patient with the Nezelof syndrome; none of these patients had histories suggestive of atopy. In addition, the mean IgE concentration was significantly elevated in patients with selective IgA deficiency, many of whom were atopic, and in those with the Wiskott-Aldrich syndrome. The highest IgD concentration (163 mg/100 ml) was found in serum from a boy with variable immunodeficiency who had a lifelong history of severe recurrent pharyngeal infections, primarily streptococcal in etiology. Recurrent staphylococcal infection was a feature common to many but not all patients with elevated serum IgE concentration. These data may prove useful in the future delineation of biologic roles for antibodies in these two immunoglobulin classes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803218      PMCID: PMC301727          DOI: 10.1172/JCI107906

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Quantitative comparison of immunoglobulins in atopic (reaginic) and nonatopic (nonreaginic) individuals: higher gamma-D levels in atopic sera.

Authors:  P F Kohler; R S Farr
Journal:  J Allergy       Date:  1967-05

Review 2.  Primary immunodeficiencies. Report of a World Health Organization Committee.

Authors:  H Fudenberg; R A Good; H C Goodman; W Hitzig; H G Kunkel; I M Roitt; F S Rosen; D S Rowe; M Seligmann; J R Soothill
Journal:  Pediatrics       Date:  1971-05       Impact factor: 7.124

3.  Measurement of IgE in normal and allergic serum by radioimmunoassay.

Authors:  G J Gleich; A K Averbeck; H A Swedlund
Journal:  J Lab Clin Med       Date:  1971-04

4.  A study of antibody responses by radioimmunodiffusion with demonstration of gamma D antigen-binding activity in four sera.

Authors:  D C Heiner; B Rose
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

5.  Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy.

Authors:  R H Buckley; S C Dees; W M O'Fallon
Journal:  Pediatrics       Date:  1968-03       Impact factor: 7.124

6.  Immunoglobulin D in serum, body fluids and lymphoid tissues.

Authors:  D S Rowe; P A Crabbé; M W Turner
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

7.  Wiskott-Aldrich syndrome. A study of 6 cases with determination of the immunoglobulins A, D, G, M and ND.

Authors:  G Berglund; O Finnström; S G Johansson; K L Möller
Journal:  Acta Paediatr Scand       Date:  1968-03

8.  Antigen combining activity associated with immunoglobulin D.

Authors:  G J Gleich; R C Bieger; R Stankievic
Journal:  Science       Date:  1969-08-08       Impact factor: 47.728

9.  Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome.

Authors:  T A Waldmann; S H Polmar; S T Balestra; M C Jost; R M Bruce; W D Terry
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

10.  Serum IgE in immune deficiency disorders.

Authors:  P McLaughlan; D R Stanworth; A D Webster; G L Asherson
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

View more
  43 in total

Review 1.  Immunoglobulin D: properties, measurement, and clinical relevance.

Authors:  A O Vladutiu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 2.  Immunopathology of atopic dermatitis.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1992

Review 3.  New insights into the enigma of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 4.  Regulation of IgE synthesis in humans.

Authors:  D Vercelli; R S Geha
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

5.  Phagocyte dysfunction in common variable immune deficiency.

Authors:  R Seger; A Wildfeuer; I O Auer; R Jeschke; D Catty; R Drew; L Dybas; G Buchinger; J Ströder; O Haferkamp
Journal:  Klin Wochenschr       Date:  1977-08-01

6.  Increased serum IgD concentrations in patients with Hodgkin's disease.

Authors:  G Corte; M Ferrarini; P Tonda; A Bargellesi
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

7.  Increase in peripheral blood 'null' cells in extrinsic bronchial asthma.

Authors:  N C Thomson; G P Sandilands; K Gray; F Reid
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

8.  Atopy as a minimal immunodeficiency?

Authors:  G R Burgio; L Nespoli; A G Ugazio
Journal:  Eur J Pediatr       Date:  1978-12-01       Impact factor: 3.183

9.  Immunoglobulin systems of human tonsils. II. Patients with chronic tonsillitis or tonsillar hyperplasia: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations.

Authors:  L Surjan; P Brandtzaeg; P Berdal
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

10.  IgM and IgD concentrations in the serum and secretions of children with selective IgA deficiency.

Authors:  A Plebani; E Mira; E Mevio; V Monafo; L D Notarangelo; A Avanzini; A G Ugazio
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.